Technical guidance and aide-mémoire on good manufacturing practice inspection of pharmaceutical manufacturing facilities with focus on reducing the incidence of antimicrobial resistance

Across the past 75 years, antimicrobial resistance (AMR) has presented a challenge to health policy, despite significant variations in response across time and between nations and regions.

Member states adopted the Global Action Plan on antibiotic Resistance in May 2015 at the Sixty-eighth World Health Assembly. This plan promotes a single health approach to address the most pressing danger to modern medicine: antibiotic resistance.

In order to reduce the prevalence of AMR and guarantee the safe and appropriate use of antibiotics, the action plan contains a framework that asks for regulatory measures and controls that are particular to antibiotics. This emphasizes how important it is for medical product regulators to be involved in both the diagnosis and prevention of AMR.